| 1 |
Kevin Xu |
Emc Ip Holding Company |
5 |
| 2 |
Peter Clemente |
Gaf Energy |
4 |
| 3 |
Xiaojun Yang |
Trident Microsystems (Far East) |
3 |
| 3 |
Hemant Thombre |
Nasdaq |
3 |
| #5 |
Mazin Gilbert |
AT&T |
2 |
| #5 |
Hung Mach |
Pharmadesign |
2 |
| #5 |
Junming Yie |
Amgen |
2 |
| #5 |
Bruce Bier |
Richards Mfg. Co., A New Jersey Limited Partnership |
2 |
| #9 |
John Maxwell |
Power-One |
1 |
| #9 |
Keith Kendall |
Aquestive Therapeutics |
1 |
| #9 |
Lara Modjeski |
Prl Usa Holdings |
1 |
| #9 |
Ilango Subramanian |
Somerset Therapeutics |
1 |
| #9 |
Rishi Bhatnager |
Zoox |
1 |
| #9 |
Veerappan Subramanian |
Somerset Therapeutics |
1 |
| #9 |
Wenju Wu |
Bristol-Myers Squibb |
1 |
| #9 |
Wendy Dawn Cornell |
IBM |
1 |
| #9 |
Zhu Chen |
Adimab |
1 |
| #9 |
Theresa Wood |
Aquestive Therapeutics |
1 |
| #9 |
Xianhai Huang |
Merck |
1 |
| #9 |
Stephen D. Tse |
Rutgers, The State University Of New Jersey |
1 |
| #9 |
Sriman BANERJEE |
Glaxosmithkline Consumer Healthcare Holdings (Us) |
1 |
| #9 |
Jean Xu |
Bristol-Myers Squibb |
1 |
| #9 |
Minsheng Zhang |
Eli Lilly |
1 |
| #9 |
Robert L. Willett |
Alcatel Lucent |
1 |
| #9 |
Yihui Zhu |
Codexis |
1 |
| #9 |
Ling Tong |
Merck |
1 |
| #9 |
Akshina Gupta |
X Development |
1 |
| #9 |
Peter N. Glynos |
— |
1 |
| #9 |
Peter Boyd |
Aquestive Therapeutics |
1 |
| #9 |
Dan Barber |
Aquestive Therapeutics |
1 |
| #9 |
Christopher Cialdella |
— |
1 |
| #9 |
Daniel S. Palka |
— |
1 |
| #9 |
Jianhong Qiu |
Colgate-Palmolive |
1 |